Literature DB >> 11115693

Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles.

P Rueda1, J Fominaya, J P Langeveld, C Bruschke, C Vela, J I Casal.   

Abstract

We have demonstrated earlier the usefulness of recombinant porcine parvovirus (PPV) virus-like particles (VLPs) as an efficient recombinant vaccine for PPV. Here, we have demonstrated that preparations of PPV VLPs could be contaminated by recombinant baculoviruses. Since these baculoviruses can be a problem for the registration and safety requirements of the recombinant vaccine, we have tested different baculovirus inactivation strategies, studying simultaneously the integrity and immunogenicity of the VLPs. These methods were pasteurization, treatment with detergents and alkylation with binary ethylenimine (BEI). The structural and functional integrity of the PPV VLPs after the inactivation treatments were analyzed by electron microscopy, hemagglutination, double antibody sandwich (DAS)-ELISA and immunogenicity studies. Binary ethylenimine and Triton X-100 inactivated particles maintained all the original structural and antigenic properties. In addition, PPV VLPs were subjected to size-exclusion chromatography to analyze the presence of VP2 monomers or any other contaminant. The resulting highly purified material was used as the standard of reference to quantify PPV VLPs in order to determine the dose of vaccine by DAS-ELISA. After immunization experiments in guinea pigs, the antibody titers obtained with all the inactivation procedures were very similar. Triton X-100 treatment was selected for further testing in animals because of the speed, simplicity and safety of the overall procedure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115693     DOI: 10.1016/s0264-410x(00)00259-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice.

Authors:  Mookkan Prabakaran; Tao Meng; Fang He; Tan Yunrui; Jia Qiang; Raymond Tzer Pin Lin; Jimmy Kwang
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

2.  Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.

Authors:  Mookkan Prabakaran; Fang He; Tao Meng; Selvaraj Madhan; Tan Yunrui; Qiang Jia; Jimmy Kwang
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

3.  Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons.

Authors:  Ralph S Baric; Boyd Yount; Lisa Lindesmith; Patrick R Harrington; Shermalyn R Greene; Fan-Chen Tseng; Nancy Davis; Robert E Johnston; David G Klapper; Christine L Moe
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.

Authors:  Mookkan Prabakaran; Selvaraj Madhan; Nayana Prabhu; Jia Qiang; Jimmy Kwang
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

5.  Production and purification of VP2 protein of porcine parvovirus expressed in an insect-baculovirus cell system.

Authors:  Hongchao Zhou; Guizhe Yao; Shangjin Cui
Journal:  Virol J       Date:  2010-12-10       Impact factor: 4.099

6.  Truncated forms of viral VP2 proteins fused to EGFP assemble into fluorescent parvovirus-like particles.

Authors:  Leona Gilbert; Jouni Toivola; Outi Välilehto; Taija Saloniemi; Claire Cunningham; Daniel White; Anna R Mäkelä; Eila Korhonen; Matti Vuento; Christian Oker-Blom
Journal:  J Nanobiotechnology       Date:  2006-12-08       Impact factor: 10.435

7.  CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.

Authors:  Gabriel Morón; Paloma Rueda; Ignacio Casal; Claude Leclerc
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

8.  Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus.

Authors:  Subaschandrabose Rajesh Kumar; Syed Musthaq Syed Khader; Tanja K Kiener; Milene Szyporta; Jimmy Kwang
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

9.  Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice.

Authors:  Balraj Premanand; Mookkan Prabakaran; Tanja K Kiener; Jimmy Kwang
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

10.  Use of bacterial artificial chromosomes in baculovirus research and recombinant protein expression: current trends and future perspectives.

Authors:  Polly Roy; Rob Noad
Journal:  ISRN Microbiol       Date:  2012-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.